Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

FDA approves once-daily Qtern for type-2 diabetes

This announcement contains inside information 28 February 2017 07:00 GMT FDA APPROVES ONCE-DAILY QTERN (DAPAGLIFLOZIN AND SAXAGLIPTIN) TABLETS FOR ADULTS WITH TYPE-2 DIABETES Qtern fixed-dose combination will provide an additional oral medicine option for patients taking Farxiga (dapagliflozin) to improve blood sugar level AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily Qtern (10mg dapagliflozin and 5mg saxagliptin) for the treatment of type-2 diabetes. The new medicine is indicated as an adjunct to diet and exercise to improve

Sm4rtLab allows virtual and remote control of optics devices

One of its kind in the world, the new virtual laboratory Sm4rtLab at the University of Eastern Finland combines the Internet of Things (IoT), cloud services, virtual reality and augmented reality, allowing physical laboratories to enter a virtual world. As a result, scientists can now operate research equipment remotely, and students have access to a completely new kind of learning environment. Sm4rtLab can be used for teaching and research from anywhere in the world. The virtual laboratory is rooted in the idea of providing new kind of support for research, as well as in creating a

Vestas receives 348 MW order in the USA

Vestas has received a firm and unconditional order in the USA comprising 174 V110-2.0 MW turbines, totalling 348 MW. Wind turbine nacelles, blades, and towers will be produced in Vestas’ Colorado factories. Additional information about the project:  Customer: UndisclosedProject name: UndisclosedLocation/Country: USANumber of MW: 348 MWNumber of 174 x V110-2.0 MW turbinesturbines/turbinetype(s):Contract type:   Supply-onlyContract scope: The contract includes supply and commissioning of the wind turbines, as well as

Goodspeed Roaming available in the newly launched ZTE Blade V8 Lite

· Goodspeed Roaming embedded in the ZTE Blade V8 Lite · With eSIM enabled ecosystem, UROS offers low-cost flat rate data roaming in 120+ countries · Provides a simple solution for roaming without bill shockUROS – Uni-fi Roaming Solutions, the leading global Roaming Solution provider today announces that Goodspeed Roaming will be embedded in the newly launched ZTE Blade V8 Lite. Goodspeed Roaming , offering low-cost flat-rate mobile data globally,

For Serneke, 2016 was another good year

Ola Serneke, President and CEO, comments on the year-end report for 2016: “The Serneke Group is able to report another year of rapid growth and good profitability. Income increased by 28 percent and amounted to nearly SEK 4 billion for 2016 and our order backlog was 37 percent higher than at the end of 2015.I am especially proud that our largest business area, Construction, ended 2016 strongly. The operating margin for the business area amounted to 3.7 percent in the fourth quarter, compared with 2.0 percent in the corresponding period in the preceding year. Serneke is now one of Sweden’

New number of votes in Bonava AB due to conversion

The number of shares and votes in Bonava AB has changed due to conversions of a total of 707,108 shares of series A to a total of 707,108 shares of series B.According to Bonava’s articles of association, owner of a share of series A has the right to request that such share is converted to a share of series B. In February, 707,108 shares of series A shares were converted to 707,108 shares of series B at the request of shareholders. Following the conversions, there were, as of February 28, the last trading day of the month, a total of 108,435,822 registered shares in Bonava AB. Of these 13,

DDM Debt AB: Q4 and year-end 2016 report

Net profit of EUR 4.2 million for the first period of operations and new EUR 50 million bond issued in 2017Highlights 2016 · Net collections of EUR 9.7M · Cash EBITDA of EUR 8.7M · Net profit for the period of EUR 4.2M · A significant transaction in Slovenia was completed in July, with a cash investment amount of EUR 17M · EUR 11M bond at 13% interest was issued in July to finance the investment in Slovenia · Loan repayments of approximately EUR 4.5M relating to the EUR 11M bond · Pipeline of future transactions remains strong Highlights fourth quarter 2016 ·

Year End Report 2016

Fourth quarter ·Net sales increased by 2% to SEK 110.6 (108.9) million. Adjusted to fixed exchange rates, net sales increased by 3%.´ · Operating profit, increased by 13% to SEK 38.4 (34.0) million. · Profit before tax, excluding non-recurring items, increased by 17% to SEK 28.9 (24.6) million. Full year  ·Net sales decreased by 2% to SEK 423.6 (431.5) million. Adjusted to fixed exchange rates, net sales were flat compared to the previous year. · Operating profit, excluding non-recurring items, decreased by 8% to SEK 139.8 (151.2) million.  ·

Completed conversion of A-shares into B-shares in Cloetta

At the request of AB Malfors Promotor, the largest shareholder in Cloetta AB (publ), Cloetta has completed conversion of 4,126,365 A-shares into B-shares.As previously announced, AB Malfors Promotor has requested conversion of 4,126,365 A-shares into B-shares. The conversion has now been registered with the Swedish Companies Registration Office. Following completion of the conversion, the total number of A-shares in Cloetta amounts to 5,735,249 and the total number of B-shares in Cloetta amounts to 282,884,050. The total number of shares in Cloetta is unchanged and after conversion

DDM Holding AG: Q4 and full year report January - December 2016

Net profit of EUR 5.3 million and strong cash flows for the yearHighlights 2016 · Net collections increased by 24% to EUR 34.2M (2015: EUR 27.5M) · Cash EBITDA increased by 35% and amounted to EUR 29.3M (2015: EUR 21.7M) · Net profit for the year of EUR 5.3M (2015: profit of EUR 1.8M)  · A landmark transaction for DDM was completed in July, with EUR 17M invested in Slovenia · EUR 11M bond at 13% interest was issued in July to finance a portfolio acquisition in Slovenia · Loan repayments of about EUR 9.2M in H2 2016 · Pipeline of future transactions remains strong

DDM Treasury Sweden AB: Q4 and full year report January - December 2016

Strong cash flows from portfoliosHighlights 2016 · Net collections decreased by 2% to SEK 223.1M (2015: SEK 228.6M) · Cash EBITDA decreased by 7% and amounted to SEK 189.0M (2015: SEK 202.7M) · Net loss for the year of SEK 2.9M (2015: profit of SEK 36.0M) · A large Hungarian transaction formally closed at the end of April 2016, resulting in significantly stronger cash flows · The SEK 31M 18% subordinated notes were repaid on their final maturity date of 30 September 2016, decreasing future financial expenses and the average cost of borrowing Highlights fourth quarter

Paulig Presidentti Special Blend 2017: Tastes from around the world and portraits from Finnish history

Paulig's newest special selection coffee, Presidentti Special Blend 2017, is a wild taste sensation. The secret of the captivating coffee enjoyment is the hand-picked, slowly ripening coffee beans high up in the mountains of Northern Sumatra. A unique portrait exhibition of former Presidents of Finland with a pinch of modern Indonesia is also arranged in connection with the launch. Presidentti Special Blend 2017 is a mouth-watering combination of the best Indonesian and South-American coffee beans. The exciting taste may make you recognise nuances of ripe figs and wild berries.

The Nomination Committee of Precise Biometrics’ proposal for the Annual General Meeting regarding election of Board, Chairman of the Board and Auditor

The nomination committee of Precise Biometrics AB makes the following proposal regarding election of members of the Board, Chairman of the Board and auditor for the period to and including the annual general meeting 2018: The number of board members shall be six, with no deputy members. The nomination committee proposes re-election of Anna Almlöf, Torbjörn Clementz, Torgny Hellström, Matts Lilja, Mats Lindoff and Synnöve Trygg, and that Torgny Hellström is re-elected as Chairman of the board. The nomination committee proposes that the fees to the board shall be unchanged.The

GomSpace (provider of nanosatellites) announces its quarterly results for the fourth quarter 2016

GS Sweden AB (the “Company”) announces its interim report for the fourth quarter of 2016. The report is available on the Company’s homepage (www.gomspace.com) . The following is taken from the quarterly report: Fourth quarter summary 1 October - 31 December 2016 (2015) · Net revenues increased to SEK 17.1 million (12.0) · Gross margin decreased to 21% (88%) · Operating profit decreased to SEK negative 16.72 million (5.98) · The revenue and gross profit has been adjusted due to changes in revenue recognition and due to elimination of partial

Change in number of shares and votes in Oncopeptides AB (publ)

During February, the number of shares and votes in Oncopeptides AB (publ) (”Oncopeptides” or the ”Company”) has increased by 16,786,215 shares and votes due to the new issues of shares that were made in connection with the listing of the Company’s shares on Nasdaq Stockholm. As of February 28, 2017, the number of shares and votes in Oncopeptides amounts to 38,828,115.About OncopeptidesOncopeptides is a research and development stage pharmaceutical company developing drugs for treatment of cancer. Since the founding of the Company in 2000, the Company has focused primarily on the

FULL YEAR REPORT 2016

THE FULL YEAR AND THE FOURTH QUARTER · Net sales amounted to MSEK 347.3 (69.1), whereof the fourth quarter MSEK 96.5 (57.4) · EBITDA was MSEK 51.7 (-71.7), whereof the fourth quarter MSEK 28.9 (-22.3) · Earnings per share amounted to SEK 1.51 (-1.46), whereof the fourth quarter SEK 1.36 (-0.46) · Cash and cash equivalents at period end amounted to MSEK 121.3 (76.5) · Acquisition of BioPhausia with a well established portfolio of drugs · A long term credit facility has been signed in conjunction with the acquisition of BioPhausia · KB9520 was outlicensed to the cancer

Change in number of shares and votes in Thule Group

Thule Group’s warrant series 2014/2017 has been exercised and as a consequence, the number of shares and votes in the company has increased by 1,036,455 in February 2017.As at 28 February 2017, there are in total 102,072,910 shares and votes in Thule Group AB (publ).---This information is information that Thule Group AB is obliged to make public pursuant to the Financial Instruments Trading Act.The information was submitted for publication at 08:00 a.m. CET on 28 February 2017.---

Trigon Agri A/S: 4Q 2016 Interim Report

2016 Highlights · Sale of 10% Trigon Agri stake in Trigon Dairy Farming Estonia for €1.5m · Restructuring of the senior management team, and cancelation of management fee · Sale of 100% Rostov farming cluster for the price of €13.3m, results in repaid debt and finances Bond interest · Rostov sale results in a one-off loss of €23.5m, mostly due to exchange rate differences · Harvest completed with reasonable winter crop yields and strong summer crop results · Russian Dairy land bank revalued, one-off loss of €5.5m included in the income statement · Strong EBITDA in

Year-End Report January - December 2016

Record sales and strong earnings for 2016 October–December 2016 · Revenues amounted to SEK 1,266 million (1,010), an increase of 25 percent · Operating profit amounted to SEK 34 million (122) and the operating margin was 2.7 percent (12.1) · Profit for the period amounted to SEK 26 million (138) · Order bookings amounted to SEK 1,650 million (1,988) · Serneke series B shares were listed on the Nasdaq Stockholm exchange on November 24 · A new share issue was carried out in connection with the listing and raised a net of SEK 598 million January–December 2016 ·

Hiddn Solutions ASA - Quarterly Report - Q4 2016

Enclosed please find Hiddn Solutions ASA’s report for the 4th quarter 2016. The 4th quarter report and company updates will be presented today, Tuesday 28 February 2017 at 0900 CET in the company's office at Cort Adelers gate 17, 7th floor. The Q4 presentation will be published on Hiddn’s homepage (www.hiddnsolutions.com). Highlights from Q4 and subsequent events: Reversed de-listing and subsequent expansion into the hardware encryption marketOn 14 November 2016, an extraordinary general meeting ("EGM") resolved to reverse the liquidation and de-listing of the Company. On 25

YEAR-END REPORT 2016

High growth and strong performance for Zinzino HealthTotal sales revenue for the fourth quarter in 2016 totalled MSEK 149.3 and is the strongest performance ever for Zinzino AB (publ). With big investments in IT systems, new products and entrance into new markets, the growth target of 20% was exceeded upon substantially and resulted in total growth of 29% for the fourth quarter. The Swedish market achieved more than 50% growth when compared to the same quarter last year, whilst Norway, Denmark, Finland and USA continued to show strong figures. The health product segment showed the

Enersize Oy has completed a private placement with strategical investors and strengthened the board

in preparation for its planned listing at Nasdaq Stockholm First NorthEnersize Oy (”Enersize”) has completed a private placement of approximately 1.2 MEUR (11 MSEK) in preparation for its planned IPO during the second quarter 2017. Among the investors are both German industrial investor Heinz Dürr Invest GmbH as well as Swedish truck manufacturing group Scania, through their newly established venture capital fund Scania Growth Capital. The capital raise was executed to accelerate Enersize’s revenue growth and to further develop the company’s proprietary software to utilize artificial

There are no items matching the current filter
There are no more items matching the current filter
Back to top